Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Periodontal Res. 2016 Jul 11;52(3):360–367. doi: 10.1111/jre.12399

Figure 2.

Figure 2

(A) TGF-β1 treatments induce HBD-2 expression assessed by quantitative real time PCR at 24hrs. (B) Pretreatment with TGF-βR1 inhibitor (SB431542) was performed prior to laser treatment and HBD-2 expression was assessed. (3) To assess other TGF-β1 downstream targets, TGFβ-Induced (TGFBI) expression was also assessed by quantitative real time PCR at 24hrs. Statistical significance was determined using Mann-Whitney test and denoted by *p<0.05, **p<0.05 and ***p<0.005.